# Filing Detail

Form F-4/A - Registration of securities, foreign private issuers, business combinations: [Amend]
SEC Accession No. 0001829126-25-009492
Filing Date
2025-11-28
Accepted
2025-11-28 06:02:08
Documents
41

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | F-4/A | veraxabiotech_f4a.htm | F-4/A | 7650527
2 | EXHIBIT 10.21 | veraxabiotech_ex10-21.htm | EX-10.21 | 323162
3 | EXHIBIT 23.1 | veraxabiotech_ex23-1.htm | EX-23.1 | 3294
4 | EXHIBIT 23.2 | veraxabiotech_ex23-2.htm | EX-23.2 | 2960
5 | EXHIBIT 23.3 | veraxabiotech_ex23-3.htm | EX-23.3 | 3067
6 | GRAPHIC | img_001.jpg | GRAPHIC | 4712
7 | GRAPHIC | img_002.jpg | GRAPHIC | 18463
8 | GRAPHIC | img_003.jpg | GRAPHIC | 14632
9 | GRAPHIC | img_004.jpg | GRAPHIC | 41515
10 | GRAPHIC | img_005.jpg | GRAPHIC | 28840
11 | GRAPHIC | img_006.jpg | GRAPHIC | 30983
12 | GRAPHIC | img_007.jpg | GRAPHIC | 28450
13 | GRAPHIC | img_008.jpg | GRAPHIC | 42503
14 | GRAPHIC | img_009.jpg | GRAPHIC | 46206
15 | GRAPHIC | img_010.jpg | GRAPHIC | 32303
16 | GRAPHIC | img_011.jpg | GRAPHIC | 21364
17 | GRAPHIC | img_012.jpg | GRAPHIC | 17503
18 | GRAPHIC | img_013.jpg | GRAPHIC | 51497
19 | GRAPHIC | img_014.jpg | GRAPHIC | 28215
20 | GRAPHIC | img_015.jpg | GRAPHIC | 20408
21 | GRAPHIC | img_016.jpg | GRAPHIC | 26018
22 | GRAPHIC | img_017.jpg | GRAPHIC | 38833
23 | GRAPHIC | img_018.jpg | GRAPHIC | 30157
24 | GRAPHIC | img_019.jpg | GRAPHIC | 25219
25 | GRAPHIC | img_020.jpg | GRAPHIC | 49788
26 | GRAPHIC | img_021.jpg | GRAPHIC | 29171
27 | GRAPHIC | img_022.jpg | GRAPHIC | 48496
28 | GRAPHIC | img_023.jpg | GRAPHIC | 21661
29 | GRAPHIC | img_024.jpg | GRAPHIC | 26895
30 | GRAPHIC | img_025.jpg | GRAPHIC | 75374
31 | GRAPHIC | img_026.jpg | GRAPHIC | 45656
32 | GRAPHIC | img_027.jpg | GRAPHIC | 46003
33 | GRAPHIC | img_028.jpg | GRAPHIC | 33144
34 | GRAPHIC | img_029.jpg | GRAPHIC | 17235
35 | GRAPHIC | img_030.jpg | GRAPHIC | 33268
36 | GRAPHIC | img_031.jpg | GRAPHIC | 33585
37 | GRAPHIC | img_032.jpg | GRAPHIC | 47911
38 | GRAPHIC | img_033.jpg | GRAPHIC | 41986
39 | GRAPHIC | img_034.jpg | GRAPHIC | 52358
40 | GRAPHIC | annexd_001.jpg | GRAPHIC | 3604
41 | GRAPHIC | ex10-21_001.jpg | GRAPHIC | 5712
| Complete submission text file | 0001829126-25-009492.txt |  | 9587443

Mailing Address C/O WINSTON & STRAWN LLP 800 CAPITOL ST., STE 2400 HOUSTON TX 77002
Business Address C/O WINSTON & STRAWN LLP 800 CAPITOL ST., STE 2400 HOUSTON TX 77002 03477204333
Voyager Acquisition Corp./Cayman Islands (Filer) CIK: 0002006815 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-4/A | Act: 33 | File No.: 333-289108-02 | Film No.: 251532250
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address TALACKER 35 ZURICH Switzerland 8001
Business Address TALACKER 35 ZURICH Switzerland 8001 41443858450
Veraxa Biotech Holding AG (Filer) CIK: 0002079109 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-4/A | Act: 33 | File No.: 333-289108 | Film No.: 251532248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address TALACKER 35 ZURICH Switzerland 8001
Business Address TALACKER 35 ZURICH Switzerland 8001 41443858450
Veraxa Biotech AG (Filer) CIK: 0002079364 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-4/A | Act: 33 | File No.: 333-289108-01 | Film No.: 251532249
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)